Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

NCT05073484 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the disclosed global research data on the same target drugs, the company has carefully considered and decided to terminate the project to optimize the existing research pipeline.

Conditions

Interventions

Sponsor

Bio-Thera Solutions